ReviewMolecular biology of the cell2025
Innate immune cross-talk: The central role of neutrophils and macrophages in ANCA-associated vasculitis.
Review in Molecular biology of the cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of rare but severe autoimmune diseases characterized by necrotizing inflammation of small blood vessels, leading to organ damage, particularly in the kidneys and respiratory tract. The current understanding of AAV pathogenesis has moved beyond a simple model of autoantibody-mediated damage to recognize a complex, self-sustaining inflammatory circuit. Central to this circuit is a dysregulated triad between neutrophils, macrophages, and the vascular endothelium. This review synthesizes our current understanding of this innate immune axis, detailing the pathogenic sequence from the initial loss of tolerance to the subsequent inflammatory priming event that triggers the pathogenic activation of neutrophils. The chronicity of AAV arises from powerful feed-forward amplification loops that sustain inflammation, which are cemented by the active suppression of the body's intrinsic resolution pathways. Finally, we discuss how advanced bioengineered platforms, such as vasculitis-on-a-chip models, are essential for deconstructing this complex pathology and are poised to accelerate the development of a new generation of targeted, pro-resolution therapies. This review provides a comprehensive framework for understanding the central role of neutrophil-macrophage cross-talk in the perpetuation of AAV.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.